Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Eg, Bevan"'
Autor:
Eg, Bevan, Sd, Pringle, Pc, Waller, Al, Herrick, Jg, Findlay, Gordon Murray, Ha, Carmichael, Ar, Lorimer, Jl, Reid, Rj, Weir
Publikováno v:
Europe PubMed Central
The objective of this study was to examine the contribution of beta-blockade to antihypertensive treatment regimens including an angiotensin converting enzyme inhibitor or a calcium antagonist. The effects on BP control, adverse events, and plasma ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ef9b0e3821b1bf02163393404cc341c3
https://pubmed.ncbi.nlm.nih.gov/8450527
https://pubmed.ncbi.nlm.nih.gov/8450527
Autor:
Eg, Bevan, Sd, Pringle, Pc, Waller, Al, Herrick, Jg, Findlay, Gordon Murray, Ha, Carmichael, Jl, Reid, Rj, Weir, Ar, Lorimer
Publikováno v:
Europe PubMed Central
The antihypertensive, biochemical and adverse effects of captopril, hydralazine, nifedipine and placebo were compared in 160 patients with BP inadequately controlled by atenolol 100 mg daily plus bendrofluazide 5 mg daily. Treatments were given for u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af789a0fb71dcb66fc7c9f7c2df1f7c7
http://europepmc.org/abstract/med/8095558
http://europepmc.org/abstract/med/8095558
Autor:
Bevan EG; University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow., Chee LC, McGhee SM, McInnes GT
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1993 Feb; Vol. 35 (2), pp. 204-7.
Autor:
Bevan EG; University Department of Medicine and Therapeutics, Western Infirmary, Glasgow., Currie EM, McGhee SM, McInnes GT
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1993 Feb; Vol. 35 (2), pp. 152-5.
Autor:
Bevan EG; Western Infirmary, Glasgow, Scotland., McInnes GT, Aldigier JC, Conte JJ, Grunfeld JP, Harper SJ, Meyer BH, Pauly N, Wilkinson R
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1993 Feb; Vol. 35 (2), pp. 128-35.
Autor:
Bevan EG; Glasgow Blood Pressure Clinic, Western Infirmary, UK., Pringle SD, Waller PC, Herrick AL, Findlay JG, Murray GD, Carmichael HA, Lorimer AR, Reid JL, Weir RJ, et. al.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 1993 Feb; Vol. 7 (1), pp. 89-93.
Autor:
Bevan EG; Glasgow Blood Pressure Clinic, Western Infirmary, UK., Pringle SD, Waller PC, Herrick AL, Findlay JG, Murray GD, Carmichael HA, Reid JL, Weir RJ, Lorimer AR, et. al.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 1993 Feb; Vol. 7 (1), pp. 83-8.
Autor:
Bevan EG; University Department of Medicine and Therapeutics, Western Infirmary, Glasgow., Findlay JG, Murray GD, McInnes GT
Publikováno v:
Journal of the Royal College of Physicians of London [J R Coll Physicians Lond] 1992 Oct; Vol. 26 (4), pp. 367-71.
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
Autor:
Bevan EG; University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK., Connell JM, Doyle J, Carmichael HA, Davies DL, Lorimer AR, McInnes GT
Publikováno v:
Journal of hypertension [J Hypertens] 1992 Jul; Vol. 10 (7), pp. 607-13.
Autor:
Bevan EG; University Department of Medicine and Therapeutics, Western Infirmary, Glasgow., McInnes GT
Publikováno v:
Scottish medical journal [Scott Med J] 1992 Apr; Vol. 37 (2), pp. 53-4.